Page last updated: 2024-08-26

tretazicar and Experimental Mammary Neoplasms

tretazicar has been researched along with Experimental Mammary Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Djeha, HA; Irvine, AS; Lipinski, KS; Mountain, A; Pelech, S; Todryk, SM; Wrighton, CJ1
Donaldson, J; Morgan, JE; Talbot, K; Twentyman, PR; Workman, P; Wright, KA1

Other Studies

2 other study(ies) available for tretazicar and Experimental Mammary Neoplasms

ArticleYear
Antitumor immune responses mediated by adenoviral GDEPT using nitroreductase/CB1954 is enhanced by high-level coexpression of heat shock protein 70.
    Cancer gene therapy, 2005, Volume: 12, Issue:6

    Topics: Adenoviridae; Animals; Apoptosis; Aziridines; Female; Genes, Transgenic, Suicide; Genetic Vectors; Granulocyte-Macrophage Colony-Stimulating Factor; HSP70 Heat-Shock Proteins; Interferon-gamma; Mammary Neoplasms, Experimental; Mice; Nitroreductases; Prodrugs; Proteomics; T-Lymphocytes; Transfection; Up-Regulation

2005
CB 1954 revisited. II. Toxicity and antitumour activity.
    Cancer chemotherapy and pharmacology, 1986, Volume: 16, Issue:1

    Topics: Animals; Aziridines; Azirines; Colonic Neoplasms; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Interactions; Humans; Lomustine; Mammary Neoplasms, Experimental; Melphalan; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Neoplasms, Experimental; Sarcoma, Experimental

1986